SSRF: Surgical Stabilization for Rib Fractures

Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Recruiting
CT.gov ID
NCT04081233
Collaborator
National Center for Advancing Translational Science (NCATS) (NIH)
150
1
2
34.2
4.4

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the usual care alone to usual care plus early surgical stabilization in adult trauma patients who have been admitted with rib fractures, to evaluate for heterogeneity of treatment effect in high risk subgroups and to determine the the impact of multiple rib fractures on post-discharge health status and time to return to work or usual physical activity.

Condition or Disease Intervention/Treatment Phase
  • Procedure: surgical stabilization
  • Procedure: Usual care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Early Stabilization of Rib Fractures on Patient-Centered Outcomes: A Randomized Clinical Trial
Actual Study Start Date :
Feb 23, 2020
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Early surgical stabilization

This arm will include early surgical stabilization (within 72 hours of admission) in addition to the usual care received for patients with multiple rib fractures. Usual care will involve pain management.

Procedure: surgical stabilization
Surgical procedure utilizing any commercially available internal rib fixation system
Other Names:
  • Rib plating
  • Active Comparator: Usual care

    This arm will be usual care only. Usual care will include pain managment.

    Procedure: Usual care
    Usual care typically consists of breathing exercises and pain control,often including opioids

    Outcome Measures

    Primary Outcome Measures

    1. Hospital Length of Stay [180 days after admission]

      Number of days patient is in the hospital

    Secondary Outcome Measures

    1. Mortality [180 days after admission]

      Death following trauma injury involving rib fractures

    2. Incidence of respiratory failure requiring mechanical ventilation greater than 24 hours [24 hours after hospital admission]

      number of patients who require mechanical ventilation greater than 24 hours

    3. Incidence of tracheostomy [Hospital discharge]

      number of patients requiring a tracheostomy due to prolonged mechanical ventilation

    4. Inpatient incidence of pneumonia [6 months after admission]

      number of patients diagnosed with pneumonia with greater than 10,000 cfu/ml on bronchioalveolar lavage or clinical diagnosis of pneumonia with subsequent antibiotic coverage

    5. Utilization of regional anesthesia [6 months after admission]

      Number of patients utilizing regional anesthesia such as epidural, paravertebral, intercostal or serratus plane anesthesia

    6. Opioid usage [6 months post admission]

      Number of patients requiring opioid medications for pain control

    7. Ventilator free days [Hospital discharge]

      Number of inpatient hospital days patients did not require mechanical ventilation

    8. Intensive Care Unit (ICU) free days [Hospital discharge]

      Number of inpatient hospital days patient was not in ICU

    9. Hospital (ICU) free days [30 days post admission]

      Number of days patient was not in the hospital during the first 30 days after admission.

    10. Re-intervention rates for surgical complications [180 days post admission]

      The number of times a procedure was required to treat surgical complications

    11. Health status at 30 days post admission [30 days post admission]

      Health status measured by the patients answers to the EuroQol-5D-5L questionnaire which is based in a scale form 0-100 with higher scores indicating a better outcome.

    12. Health status at 90 days post admission [90 days post admission]

      Health status measured by the patients answers to the EuroQol-5D-5L questionnaire which is based in a scale form 0-100 with higher scores indicating a better outcome.

    13. Health status at 180 days post admission [180 days post admission]

      Health status measured by the patients answers to the EuroQol-5D-5L questionnaire which is based in a scale form 0-100 with higher scores indicating a better outcome.

    14. Time from injury to return to work or usual activity [180 days post admission]

      Number of days from time of injury until patient was able to return to work or usual activities prior to injury per patient's assessment

    15. Time from injury to resolution of pain [180 days post admission]

      Number of days from time of injury to time patient verbalized pain was resolved

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Blunt trauma mechanism

    • Severe chest wall injury (defined by one of the 3 below):

    Radiographic flail segment (defined as greater than 2 fractures in greater than 3 consecutive ribs) or greater than 5 consecutive rib fractures or greater than 1 rib fractures with bicortical displacement

    • At least one true rib (1-7) fractured and accessible for stabilization
    Exclusion Criteria:
    • Severe traumatic brain injury (best resuscitated GCS less than 8 as measured at 24 hours)

    • Spinal cord injury

    • Pre-existing congestive heart failure or oxygen-dependent pulmonary disease

    • Any reason for which SSRF could not occur within 72 hours of admission

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The University of Texas Health Science Center at Houston Houston Texas United States 77030

    Sponsors and Collaborators

    • The University of Texas Health Science Center, Houston
    • National Center for Advancing Translational Science (NCATS)

    Investigators

    • Principal Investigator: David Meyers, MD, The University of Texas Health Science Center, Houston

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    David E. Meyer, MD, MS, FACS, Assistant Professor, The University of Texas Health Science Center, Houston
    ClinicalTrials.gov Identifier:
    NCT04081233
    Other Study ID Numbers:
    • HSC-MS-19-0649
    • KL2TR003168
    First Posted:
    Sep 9, 2019
    Last Update Posted:
    Mar 22, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 22, 2022